Gilder Gagnon Howe & CO LLC Impel Pharmaceuticals Inc Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.71 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$2.59 - $4.0 $168 - $260
-65 Reduced 0.05%
142,631 $534,000
Q3 2022

Nov 14, 2022
BUY
$5.78 - $9.32 $30,645 - $49,414
5,302 Added 3.86%
142,696 $695,000
Q2 2022

Aug 15, 2022
BUY
$5.83 - $10.12 $801,007 - $1.39 Million
137,394 New
137,394 $1.28 Million

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email